These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28637435)

  • 1. Association between polymorphism rs11200638 in the HTRA1 gene and the response to anti-VEGF treatment of exudative AMD: a meta-analysis.
    Zhou YL; Chen CL; Wang YX; Tong Y; Fang XL; Li L; Wang ZY
    BMC Ophthalmol; 2017 Jun; 17(1):97. PubMed ID: 28637435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
    Abedi F; Wickremasinghe S; Richardson AJ; Islam AF; Guymer RH; Baird PN
    Ophthalmology; 2013 Aug; 120(8):1641-8. PubMed ID: 23582991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of the association of the HTRA1 polymorphisms with the risk of age-related macular degeneration.
    Chen W; Xu W; Tao Q; Liu J; Li X; Gan X; Hu H; Lu Y
    Exp Eye Res; 2009 Sep; 89(3):292-300. PubMed ID: 19026638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of exudative age-related macular degeneration and polypoidal choroidal vasculopathy in the ARMS2/HTRA1 locus.
    Liang XY; Lai TY; Liu DT; Fan AH; Chen LJ; Tam PO; Chiang SW; Ng TK; Lam DS; Pang CP
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):3175-82. PubMed ID: 22491416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration.
    McKibbin M; Ali M; Bansal S; Baxter PD; West K; Williams G; Cassidy F; Inglehearn CF
    Br J Ophthalmol; 2012 Feb; 96(2):208-12. PubMed ID: 21558292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between variants A69S in ARMS2 gene and response to treatment of exudative AMD: a meta-analysis.
    Hu Z; Xie P; Ding Y; Yuan D; Liu Q
    Br J Ophthalmol; 2015 May; 99(5):593-8. PubMed ID: 25185256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis.
    Tong Y; Liao J; Zhang Y; Zhou J; Zhang H; Mao M
    Mol Vis; 2010 Oct; 16():1958-81. PubMed ID: 21031019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association with response to intravitreal ranibizumab for neovascular age-related macular degeneration in the Han Chinese population.
    Yuan D; Yuan D; Liu X; Yuan S; Xie P; Liu Q
    Ophthalmologica; 2013; 230(4):227-32. PubMed ID: 24080590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population.
    Leveziel N; Souied EH; Richard F; Barbu V; Zourdani A; Morineau G; Zerbib J; Coscas G; Soubrane G; Benlian P
    Mol Vis; 2007 Nov; 13():2153-9. PubMed ID: 18079691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.
    Wang VM; Rosen RB; Meyerle CB; Kurup SK; Ardeljan D; Agron E; Tai K; Pomykala M; Chew EY; Chan CC; Tuo J
    Mol Vis; 2012; 18():2578-85. PubMed ID: 23112570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement factor H and high-temperature requirement A-1 genotypes and treatment response of age-related macular degeneration.
    Tsuchihashi T; Mori K; Horie-Inoue K; Gehlbach PL; Kabasawa S; Takita H; Ueyama K; Okazaki Y; Inoue S; Awata T; Katayama S; Yoneya S
    Ophthalmology; 2011 Jan; 118(1):93-100. PubMed ID: 20678803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of response to anti-VEGF therapy in exudative age-related macular degeneration.
    Dedania VS; Grob S; Zhang K; Bakri SJ
    Retina; 2015 Mar; 35(3):381-91. PubMed ID: 25635578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration.
    Boltz A; Ruiß M; Jonas JB; Tao Y; Rensch F; Weger M; Garhöfer G; Frantal S; El-Shabrawi Y; Schmetterer L
    Ophthalmology; 2012 Aug; 119(8):1615-20. PubMed ID: 22521084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTRA1 promoter variant differentiates polypoidal choroidal vasculopathy from exudative age-related macular degeneration.
    Ng TK; Liang XY; Lai TY; Ma L; Tam PO; Wang JX; Chen LJ; Chen H; Pang CP
    Sci Rep; 2016 Jun; 6():28639. PubMed ID: 27338780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CFH Y402H and VEGF Polymorphisms and Anti-VEGF Treatment Response in Exudative Age-Related Macular Degeneration.
    Kepez Yildiz B; Ozdek S; Ergun MA; Ergun S; Yaylacioglu Tuncay F; Elbeg S
    Ophthalmic Res; 2016; 56(3):132-8. PubMed ID: 27404493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between variant Y402H in age-related macular degeneration (AMD) susceptibility gene CFH and treatment response of AMD: a meta-analysis.
    Chen H; Yu KD; Xu GZ
    PLoS One; 2012; 7(8):e42464. PubMed ID: 22905135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HTRA1 polymorphism and bilaterality in advanced age-related macular degeneration.
    Chen H; Yang Z; Gibbs D; Yang X; Hau V; Zhao P; Ma X; Zeng J; Luo L; Pearson E; Constantine R; Kaminoh Y; Harmon J; Tong Z; Stratton CA; Cameron DJ; Tang S; Zhang K
    Vision Res; 2008 Feb; 48(5):690-4. PubMed ID: 18206206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration.
    Finger RP; Wickremasinghe SS; Baird PN; Guymer RH
    Surv Ophthalmol; 2014; 59(1):1-18. PubMed ID: 24332379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration.
    Abedi F; Wickremasinghe S; Richardson AJ; Makalic E; Schmidt DF; Sandhu SS; Baird PN; Guymer RH
    Ophthalmology; 2013 Jan; 120(1):115-21. PubMed ID: 23149126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the polymorphism Y402H in the CFH gene with response to anti-VEGF treatment in age-related macular degeneration: a systematic review and meta-analysis.
    Hong N; Shen Y; Yu CY; Wang SQ; Tong JP
    Acta Ophthalmol; 2016 Jun; 94(4):334-45. PubMed ID: 27151934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.